Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 28, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - June 28, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/21/17 - "Extracting Method of Kuguacin, Pharmaceutical Composition Comprising the Kuguacin and Use Thereof" in Patent Application Approval Process (USPTO...
"Extracting Method of Kuguacin, Pharmaceutical Composition Comprising the Kuguacin and Use Thereof" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Tsai, Po-Jung; Huang, Wen-Cheng; Tsai, Tzung-Hsun; Ying, How-Ting; Hung, Ya-Ling, filed on October 4, 2016, was made
6/21/17 - ACEA Biosciences Announces Collaboration with Memorial Sloan Kettering Cancer Center on Personalized CAR T Cell Therapy
By a News Reporter-Staff News Editor at Biotech Week ACEA Biosciences and Memorial Sloan Kettering Cancer Center have entered into a collaboration to evaluate a personalized ex vivo potency assay using cancer patients' malignant pleural effusions and ACEA's xCELLigence Real-Time Cell Analysis instrument to monitor destruction of the cancer cells
6/21/17 - Allergan to Acquire Keller Medical, Inc., Adding Keller Funnel to Company's Leading Plastic Surgery Portfolio
By a News Reporter-Staff News Editor at Biotech Week Allergan plc, a leading global pharmaceutical company, announced that Allergan's wholly-owned subsidiary, Allergan Sales LLC agreed to acquire Keller Medical, Inc., a privately held medical device company and developer of the Keller Funnel . "Allergan is focused on providing technologies and
6/21/17 - Are You Choosing the Right Model? A Guide to Selecting Your Next Immuno-Oncology Model, New Webinar Hosted by Xtalks
By a News Reporter-Staff News Editor at Biotech Week In this presentation, Dr. Michelle Mack, Global Director of Scientific Engagement at Crown Bioscience Inc. will outline the latest in vivo Immuno-Oncology models and what to consider when choosing the proper model. She will also discuss how these models are used to investigate immunotherapeutic
6/21/17 - AXIM Obtains More Financing for Its Cannabinoid Therapies for MS and Bowel Diseases [Arab News (Saudi Arabia)]
AXIM Biotechnologies has secured an additional $4 million in institutional financing to advance clinical trials of its cannabinoid therapies for multiple sclerosis and irritable bowel syndrome. Some of the trials involve a chewing-gum therapy delivery system. AbbVie developed Marinola as a gel capsule.
6/21/17 - bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter Study of bb2121 Anti-BCMA CAR T Cell...
By a News Reporter-Staff News Editor at Biotech Week bluebird bio, Inc., and Celgene Corporation announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-BCMA CAR T cell therapy, in 18 patients with relapsed/refractory multiple myeloma will be presented at the American Society of Clinical O
6/21/17 - Cardioxyl Pharmaceuticals, Chapel Hill, N.C., Johns Hopkins University, Baltimore, Assigned Patent for Pyrazolone Derivatives as Nitroxyl Donors
Cardioxyl Pharmaceuticals, Chapel Hill, North Carolina, and Johns Hopkins University, Baltimore, have been assigned a patent developed by seven co-inventors for "pyrazolone derivatives as nitroxyl donors." The co-inventors are Vincent Jacob Kalish, Annapolis, Maryland, Frederick Arthur Brookfield, Abingdon, United Kingdom, Stephen Martin Courtney,
6/21/17 - Clarify Medical Core Technology Receives FDA Clearance
By a News Reporter-Staff News Editor at Biotech Week Clarify Medical, Inc. announced that it has received FDA Market Clearance for the Clarify Medical Phototherapy System, the core technology of its Clarify Home Light Therapy service, which it plans to offer to patients in November. "For people with chronic skin conditions that respond to light
6/21/17 - Clovis rockets on maintenance data in ovarian cancer [T-break Tech (Middle East)]
The company`s shares rocketed 46% on the announcement of the new clinical trial results for Rubraca in second- line and later maintenance treatment for women with platinum-sensitive ovarian cancer who have responded to their most recent platinum therapy, with Clovis suggesting it would file the data with the US FDA within the next four months.
6/21/17 - Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V To The Active Substance Colistin, Atc J01xb01, For The Period V. 1.8.2017-31.7.2019 (+ 2 X 6 Months Option). [TendersInfo (India)]
For medicinal products to be designated by the tenderer in more detail in Appendix 2 to the contract,, DAK Health intends to conclude drug treaties with the largest possible number of pharmaceutical companies with the largest possible number of pharmaceutical companies. A discount agreement within the scope of the admission model for the above- Act
6/21/17 - CTI BioPharma Appoints David R. Parkinson, M.D., Leader in Oncology Clinical Development, to Board of Directors and Announces Board Member...
By a News Reporter-Staff News Editor at Biotech Week CTI BioPharma Corp. announced that David R. Parkinson, M.D., has been appointed a Director of CTI BioPharma effective June 5, 2017. Richard L. Love, a CTI BioPharma director, will act as Interim Chairman of the Board until the Board selects a permanent successor. "We are pleased to have David
6/21/17 - Data at ASCO Show Consistent Progression-Free Survival Benefit in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma...
By a News Reporter-Staff News Editor at Biotech Week Janssen Research& Development, LLC announced longer follow-up of up to four years from the pivotal Phase 3 RESONATE? trial of IMBRUVICA vs. ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. These results will be presented today at the
6/21/17 - Development of New Tuberculosis Treatment RegimensScientific and Clinical Trial Design Considerations; Public Workshop; Request for Comments
This public workshop is intended to provide information for and gain perspective from health care providers, other U.S. Government Agencies, academic experts, industry, and other stakeholders regarding scientific and clinical trial design considerations related to the development of new TB regimens. DATES: The public workshop will be held on July 1
6/21/17 - Do you need a vitamin or mineral top-up?
Itchy or dry skin, low mood, thinning hair, low libido, tiredness and even stress could all also indicate you need more of a certain nutrient. The research, by supplement retailer Healthspan, also found 36% of those polled have made a conscious effort to boost their intake of certain vitamins and minerals because they felt they were lacking in them
6/21/17 - Dr REDDY'S MAY FILE 2 NEW DRUGS WITH FDA BY 2019
Dr Reddy's Laboratories is likely to file two new drug applications with the US Food and Drug Administration by 2019. The company is presently working on 16 active product development programmes. Out of the two applications to be filed, one drug to treat migraines has completed Phase-III trials, while another anti-cancer biologic agent is currently
6/21/17 - DR REDDY'S NEW DRUG APPLICATION
Indian pharmaceutical major Dr Reddy's Laboratories, has 16 drug applications in its research pipeline. Among them migraine treatment drug has completed Phase III trials, while phase III trials is underway for an anticancer drug. The company anticipates to submit, New Drug Application to the US Food and Drug Administration for migraine treatment in
6/21/17 - Dr Reddy`s may file two new drugs with FDA by 2019 [Tehran Times (Iran)]
According to filing with the US Securities and Exchange Commission, the city-based pharma company is expected to file the New Drug Application with US Food and Drug Administration with regard the migraine drug in 2018 while it is expected to submit license application for the cancer drug, it may approach the drug regulator in 2019.. The company`s p
6/21/17 - Emory University School of Medicine Reports Findings in Coagulants (Platelet-Microcapsule Hybrids Leverage Contractile Force for Targeted Delivery of...
According to news reporting from Atlanta, Georgia, by NewsRx journalists, research stated, "We report a cell-mediated, targeted drug delivery system utilizing polyelectrolyte multilayer capsules that hybridize with the patient's own platelets upon intravenous administration. Financial supporters for this research include National Heart, Lung, and..
6/21/17 - ePharmacies Market: Set to Surge Significantly During 2017 2025 : Persistence Market Research
The ePharmacies can effectively address some customer issues such as comprehensive information on the drugs or alternative for the prescription drug, easy access to the medicines that are otherwise hard to find, medicine records, and others.New York, NY 06/20/2017 ePharmacy is an online pharmacy which operates over the Internet and sends the
6/21/17 - Everything pharma companies hate
Earlier this year, my work to lower drug prices for Ohio families was described as combining every policy idea drug lobbyists hate.. Any revenues collected through the bill would be reinvested in future drug research and development at the National Institutes of Health. Thanks to the Affordable Care Act, we have made some progress in lowering
6/21/17 - Everything pharmaceutical companies hate
Earlier this year, my work to lower drug prices for Ohio families was described as combining every policy idea drug lobbyists hate. And that s something I m pretty proud of. Any revenues collected through the bill would be reinvested in future drug research and development at the National Institutes of Health. Thanks to the Affordable C
6/21/17 - FDA approves ReNeurons cryopreserved formulation of retinal stem cell therapy candidate [Tehran Times (Iran)]
The FDA has approved the cryopreserved formulation of ReNeuron Groups human retinal progenitor cell therapeutic candidate, according to a company press release. We are delighted that the FDA has approved the use of the cryopreserved formulation of our hRPC retinal cell therapy candidate in our ongoing clinical development programs, Olav Helleb, CEO
6/21/17 - FDA Reports Critical Drug Shortages [Sudan Tribune]
The U.S. Food and Drug Administration says that it`s working with the drug company Pfizer to remedy a shortage of important injectable medications, including emergency syringes of epinephrine. The drugs in short supply are made by the Pfizer company Hospira. In some cases, the FDA is extending expiration dates.
6/21/17 - Findings from Ben-Gurion University of the Negev Yields New Data on Transdermal Delivery (Continuous Transdermal Delivery of L-DOPA Based on a...
Findings from Ben-Gurion University of the Negev Yields New Data on Transdermal Delivery. According to news reporting originating in Beer Sheva, Israel, by NewsRx journalists, research stated, "When levodopa is administered orally, it is eliminated from the body very quickly resulting in a series of sharp fluctuations in its blood concentrations.
6/21/17 - Findings from University of California Reveals New Findings on Drug Delivery Systems (High-Throughput Quantification of Nanoparticle Degradation...
According to news reporting originating from Los Angeles, California, by NewsRx correspondents, research stated, "Design and synthesis of degradable nanoparticles are very important in drug delivery and biosensing fields. Funders for this research include Howard Hughes Medical Institute, National Institute of Neurological Disorders and Stroke,...
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415